{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:02:09Z","timestamp":1780923729475,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,1]],"date-time":"2027-05-01T00:00:00Z","timestamp":1809129600000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015131","name":"Foundation for Sarcoidosis Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.resmer.2026.101278","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:23:30Z","timestamp":1776295410000},"page":"101278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Real-world evidence on hospitalization, infection, and vascular outcomes among interstitial lung disease subtypes"],"prefix":"10.1016","volume":"89","author":[{"given":"Wen-Cheng","family":"Chao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9477-3837","authenticated-orcid":false,"given":"Shu-Yi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.resmer.2026.101278_bib0001","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMra2005230","article-title":"Spectrum of fibrotic lung diseases","volume":"383","author":"Wijsenbeek","year":"2020","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.resmer.2026.101278_bib0002","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/jama.2024.3669","article-title":"Interstitial Lung Disease: a review","volume":"331","author":"Maher","year":"2024","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.resmer.2026.101278_bib0003","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary Fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N Engl J Med"},{"issue":"10354","key":"10.1016\/j.resmer.2026.101278_bib0004","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(22)01052-2","article-title":"Interstitial lung diseases","volume":"400","author":"Wijsenbeek","year":"2022","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.resmer.2026.101278_bib0005","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.3899\/jrheum.141182","article-title":"Connective tissue disease-associated interstitial lung diseases (CTD-ILD) - report from OMERACT CTD-ILD working group","volume":"42","author":"Khanna","year":"2015","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.resmer.2026.101278_bib0006","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/annrheumdis-2020-217230","article-title":"Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)","volume":"80","author":"Spagnolo","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.resmer.2026.101278_bib0007","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.chest.2015.12.026","article-title":"Patients with fibrotic interstitial lung disease hospitalized for acute Respiratory worsening: a large cohort analysis","volume":"149","author":"Moua","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.resmer.2026.101278_bib0008","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12931-023-02588-y","article-title":"Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registry","volume":"25","author":"Buschulte","year":"2024","journal-title":"Respir Res"},{"issue":"6","key":"10.1016\/j.resmer.2026.101278_bib0009","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1164\/rccm.202309-1708OC","article-title":"Hospitalization rates in interstitial lung disease: an analysis of the Pulmonary fibrosis foundation registry","volume":"210","author":"King","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.resmer.2026.101278_bib0010","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.rmed.2010.02.008","article-title":"Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis","volume":"104","author":"Nathan","year":"2010","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.resmer.2026.101278_bib0011","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12931-020-01570-2","article-title":"Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights","volume":"21","author":"Ruffenach","year":"2020","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.resmer.2026.101278_bib0012","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41584-023-01044-x","article-title":"Systemic sclerosis interstitial lung disease: unmet needs and potential solutions","volume":"20","author":"Liakouli","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.resmer.2026.101278_bib0013","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20929208","article-title":"Factors associated with sepsis risk in immune-mediated inflammatory diseases receiving tumor necrosis factor inhibitors: a nationwide study","volume":"12","author":"Chao","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"5","key":"10.1016\/j.resmer.2026.101278_bib0014","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1183\/13993003.00829-2015","article-title":"Connective tissue diseases, multimorbidity and the ageing lung","volume":"47","author":"Spagnolo","year":"2016","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.resmer.2026.101278_bib0015","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.chest.2017.03.033","article-title":"The role of infection in interstitial lung diseases: a review","volume":"152","author":"Azadeh","year":"2017","journal-title":"Chest"},{"issue":"21","key":"10.1016\/j.resmer.2026.101278_bib0016","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Raghu","year":"2012","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.resmer.2026.101278_bib0017","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial Lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.resmer.2026.101278_bib0018","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for Systemic sclerosis-Associated Interstitial Lung Disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.resmer.2026.101278_bib0019","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S2213-2600(20)30554-3","article-title":"Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Behr","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.resmer.2026.101278_bib0020","doi-asserted-by":"crossref","first-page":"ooad035","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"issue":"6","key":"10.1016\/j.resmer.2026.101278_bib0021","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.resmer.2026.101278_bib0022","doi-asserted-by":"crossref","DOI":"10.1177\/17534666241280704","article-title":"Real-world antifibrotic treatment patterns in patients with idiopathic pulmonary fibrosis: retrospective analyses of two large healthcare administrative databases in the United States","volume":"18","author":"Qiu","year":"2024","journal-title":"Ther Adv Respir Dis"},{"issue":"10","key":"10.1016\/j.resmer.2026.101278_bib0023","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.28045","article-title":"Strategies to turn real-world data into real-world knowledge","volume":"4","author":"Hong","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"57 Suppl 7","key":"10.1016\/j.resmer.2026.101278_bib0024","article-title":"Randomized controlled trials and real-world data: differences and similarities to untangle literature data","volume":"57","author":"Monti","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.resmer.2026.101278_bib0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jama.2024.4088","article-title":"The integration of clinical trials with the practice of medicine: repairing a house divided","volume":"332","author":"Angus","year":"2024","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.resmer.2026.101278_bib0026","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1513\/AnnalsATS.202001-035SD","article-title":"The Pulmonary Fibrosis Foundation Patient Registry. Rationale, design, and methods","volume":"17","author":"Wang","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.resmer.2026.101278_bib0027","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1378\/chest.13-2424","article-title":"Outcomes after hospitalization in idiopathic pulmonary fibrosis: a cohort study","volume":"147","author":"Brown","year":"2015","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.resmer.2026.101278_bib0028","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12931-021-01851-4","article-title":"Hospitalizations in patients with idiopathic pulmonary fibrosis","volume":"22","author":"Kim","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.resmer.2026.101278_bib0029","article-title":"Mortality and Respiratory-related hospitalizations in idiopathic pulmonary fibrosis not treated with antifibrotics","volume":"8","author":"Cottin","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10.1016\/j.resmer.2026.101278_bib0030","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.chest.2019.10.032","article-title":"Viral infection increases the risk of idiopathic pulmonary fibrosis: a meta-analysis","volume":"157","author":"Sheng","year":"2020","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.resmer.2026.101278_bib0031","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12967-021-03159-9","article-title":"Virus infection induced pulmonary fibrosis","volume":"19","author":"Huang","year":"2021","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.resmer.2026.101278_bib0032","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1164\/rccm.201805-0825OC","article-title":"Impaired Cytomegalovirus immunity in idiopathic pulmonary fibrosis lung transplant recipients with short telomeres","volume":"199","author":"Popescu","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.resmer.2026.101278_bib0033","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.resmer.2026.101278_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7305a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2024-25 influenza season","volume":"73","author":"Grohskopf","year":"2024","journal-title":"MMWR Recomm Rep"},{"issue":"32","key":"10.1016\/j.resmer.2026.101278_bib0035","doi-asserted-by":"crossref","first-page":"696","DOI":"10.15585\/mmwr.mm7332e1","article-title":"Use of Respiratory syncytial virus vaccines in adults aged \u226560 years: updated recommendations of the Advisory Committee on Immunization Practices - United States, 2024","volume":"73","author":"Britton","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.resmer.2026.101278_bib0036","article-title":"Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): evolving concept of CT findings, pathology and management","volume":"9","author":"Yoo","year":"2022","journal-title":"Eur J Radiol Open"},{"issue":"1","key":"10.1016\/j.resmer.2026.101278_bib0037","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-000935","article-title":"Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study","volume":"5","author":"Mehta","year":"2019","journal-title":"RMD Open"},{"issue":"5","key":"10.1016\/j.resmer.2026.101278_bib0038","article-title":"Systemic sclerosis-associated pulmonary hypertension: spectrum and impact","volume":"11","author":"Naranjo","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.resmer.2026.101278_bib0039","article-title":"Myositis interstitial lung disease and autoantibodies","volume":"10","author":"Chaudhry","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10.1016\/j.resmer.2026.101278_bib0040","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1183\/13993003.01537-2014","article-title":"Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction","volume":"46","author":"Raghu","year":"2015","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.resmer.2026.101278_bib0041","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.chest.2020.04.046","article-title":"The trouble with group 3 pulmonary hypertension in interstitial lung disease: dilemmas in diagnosis and the conundrum of treatment","volume":"158","author":"King","year":"2020","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.resmer.2026.101278_bib0042","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.chest.2022.02.012","article-title":"Screening strategies for pulmonary hypertension in patients with interstitial lung disease: a multidisciplinary Delphi study","volume":"162","author":"Rahaghi","year":"2022","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.resmer.2026.101278_bib0043","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12890-021-01608-1","article-title":"Efficacy of treatment with corticosteroids for fibrotic hypersensitivity pneumonitis: a propensity score-matched cohort analysis","volume":"21","author":"Ejima","year":"2021","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resmer.2026.101278_bib0044","article-title":"Progressive fibrosing interstitial lung disease in rheumatoid arthritis: a retrospective study","volume":"9","author":"Denis","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.resmer.2026.101278_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1341321","article-title":"Rate of severe and fatal infections in a cohort of patients with interstitial lung disease associated with rheumatoid arthritis: a multicenter prospective study","volume":"15","author":"Mena-Vazquez","year":"2024","journal-title":"Front Immunol"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041226000322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041226000322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:12:11Z","timestamp":1780920731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041226000322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":45,"alternative-id":["S2590041226000322"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2026.101278","relation":{},"ISSN":["2590-0412"],"issn-type":[{"value":"2590-0412","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world evidence on hospitalization, infection, and vascular outcomes among interstitial lung disease subtypes","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2026.101278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 SPLF and Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101278"}}